Challenges in hypotensive therapy: the role of calcium antagonists

Challenges in hypotensive therapy: the role of calcium antagonists

The paper addresses the role of calcium channel blockers (CCB) in the treatment of patients with arterial hypertension and concomitant pathology. The authors present the findings of the recent studies on CCB effects on renal function, bronchial function, and systemic inflammation. This additional in...

Full description

Bibliographic Details
Main Authors:	E. O. Taratukhin, N. V. Teplova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2013-04-01
Series:	Российский кардиологический журнал
Subjects:	calcium channel blockers inflammation copd nephropathy lercanidipine
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/366

Similar Items

HYPERTENSION IN POSTMENOPAUSAL WOMEN: RATIONALE FOR THE USE OF CALCIUM CHANNEL BLOCKERS IN ANTIHYPERTENSIVE THERAPY
by: O. A. Kislyak, et al.
Published: (2017-07-01)

THE EFFECTIVENESS OF LERCANIDIPINE IN REDUCING THE RISK OF ARTERIAL HYPERTENSION COMPLICATIONS
by: E. EL. Trisvetova
Published: (2015-09-01)

POSITIONS OF CALCIUM CHANNEL BLOCKER LERCANIDIPINE ACCORDING TO EVIDENCE BASED CARDIOLOGY
by: Yu. V. Lukina, et al.
Published: (2016-01-01)

OPTIMIZING THE TREATMENT OF PATIENTS WITH HYPERTENSION AND CORONARY HEART DISEASE WITH LERCANIDIPINE
by: E. L. Trisvetova
Published: (2015-09-01)

RESISTANT HYPERTENSION IN A PATIENT WITH METABOLIC SYNDROME
by: O. M. Drapkina, et al.
Published: (2017-01-01)

Calcium antagonist lercanidipine in hypertension
by: G. A Baryshnikova, et al.
Published: (2014-03-01)

Pleiotropic features of dihydropyridine calcium channel antagonists
by: G S Anikin
Published: (2014-09-01)

ANTIHYPERTENSIVE EFFICACY AND TOLERABILITY OFLERCANIDIPINE IN DAILY CLINICAL PRACTICE. THE ELYPSE STUDY
by: Vivencio Barrios, et al.
Published: (2010-08-01)

New Insights into the Nephroprotective Potential of Lercanidipine
by: Joanna Hajdys, et al.
Published: (2023-09-01)

Real and potential benefits of third-generation calcium antagonists
by: A A Kirichenko
Published: (2013-03-01)

CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01)

Arterial hypertension treatment with a calcium channel blocker and an ACE inhibitor. Benefits of combination therapy
by: E. O. Taratukhin
Published: (2013-06-01)

Fixed combinations in the management of hypertension: perspectives on lercanidipine – enalapril
by: Vivencio Barrios, et al.
Published: (2008-08-01)

DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
by: S. R. Gilyarevskyi, et al.
Published: (2014-04-01)

The Effects of Eprosartan Mesylate and Lercanidipine on Reducing Microalbuminuria in Patients with Nephropathy due to Type 2 Diabetes
by: Botir T. Daminov, PhD, ScD, et al.
Published: (2013-06-01)

Calcium Channel Blockers and the Risk of Exacerbation in Patients with Chronic Obstructive Pulmonary Disease: A Nationwide Study of 48,488 Outpatients
by: Ema Rastoder, et al.
Published: (2023-07-01)

A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
by: E. I. Emelina, et al.
Published: (2015-11-01)

LERCANIDIPINE, CALCIUM CHANNEL BLOCKER OF THE THIRD GENERATION: NEW POSSIBILITIES IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: O. D. Ostroumova, et al.
Published: (2015-09-01)

Lercanidipine as a calcium antagonist of the third generation: a review of effectiveness in the hypertension treatment
by: V S Zadionchenko, et al.
Published: (2013-12-01)

Vascular mechanisms underlying the hypotensive effect of Rumex acetosa
by: Hafiz Misbah-Ud-Din Qamar, et al.
Published: (2018-01-01)

Calcium antagonists: on the way to expanding the indications
by: V V Fomin
Published: (2010-06-01)

LERCANIDIPINE IN THE TREATMENT OF ARTERIAL HYPERTENSION
by: C. Beckey, et al.
Published: (2009-08-01)

The role of calcium antagonists in the treatment of cardiovascular disease: Focus on diltiazem
by: G. A Baryshnikova, et al.
Published: (2015-03-01)

Optimizing therapy for cardiovascular diseases: proven organ-protective and preventive effects of pitavastatin and lercanidipine: A review
by: Marina G. Bubnova
Published: (2022-07-01)

N-/T-Type vs. L-Type Calcium Channel Blocker in Treating Chronic Kidney Disease: A Systematic Review and Meta-Analysis
by: Mingming Zhao, et al.
Published: (2023-02-01)

Calcium Channels in the Heart: Disease States and Drugs
by: Kajol Shah, et al.
Published: (2022-03-01)

Comparing the Efficacy of Angiotensin Converting Enzyme Inhibitors with Calcium Channel Blockers on the Treatment of Diabetic Nephropathy: A Meta-Analysis
by: Zhaowei ZHANG, et al.
Published: (2019-02-01)

The Roles of Calcium Ions in Parkinson’s Disease: Calcium Channel Inhibitors as a Novel Agents?
by: Md Reyaz Alam, et al.
Published: (2022-10-01)

Corrected QT interval in electrocardiogram recordings in patients treated with calcium channel blockers
by: Małgorzata Wołek, et al.
Published: (2023-06-01)

Calcium-channel blockers for the prevention of stroke: from scientific evidences to the clinical practice
by: S. Taddei
Published: (2013-05-01)

Calcium Channel Blocker Overdose Simulation
by: Michael Maniaci, et al.
Published: (2015-01-01)

Calcium channel blockers- Induced iatrogenic gingival hyperplasia: Case series
by: G Agnes Golda Priyadarshini, et al.
Published: (2023-01-01)

The effects of prior calcium channel blocker therapy on creatine kinase-MB levels after percutaneous coronary interventions
by: Oyku Gulmez, et al.
Published: (2008-12-01)

Use of Calcium Channel Blockers is Associated with Mortality in Patients with Chronic Kidney Disease
by: Dominik G. Haider, et al.
Published: (2015-12-01)

Practical Radiosynthesis and Preclinical Neuroimaging of [11C]isradipine, a Calcium Channel Antagonist
by: Benjamin H. Rotstein, et al.
Published: (2015-05-01)

Distal extracellular teneurin region (teneurin C-terminal associated peptide; TCAP) possesses independent intracellular calcium regulating actions, in vitro: A potential antagonist of corticotropin-releasing factor (CRF)
by: David W. Hogg, et al.
Published: (2022-12-01)

Once was not enough: A case report of the concomitant intoxication of amlodipine (calcium channel blocker) and clonazepam (benzodiazepine)
by: Swotantra Gautam, et al.
Published: (2022-07-01)

Effect of calcium channel blockers on gingival tissues in hypertensive patients in Lagos, Nigeria: A pilot study
by: Kehinde Adesola Umeizudike, et al.
Published: (2017-01-01)

Penggunaan Calcium Channel Blocker pada Tatalaksana Anestesi Clipping Aneurisma Otak
by: Fanda Ayyu Rindiati, et al.
Published: (2019-10-01)

Discovery and Development of Calcium Channel Blockers
by: Théophile Godfraind
Published: (2017-05-01)